Skip to main content Accessibility help
  • Online publication date: March 2015

Chapter 13 - Non-neoplastic diseases of bones and joints


1. Klein MJ, Memoli VA. Orthopaedic specimen preparation. What pathologists should know and do. Seminars in Diagnostic Pathology 2011; 28(1): 4–12.
2. Brain EB. The Preparation of Decalcified Sections. Springfield, IL: Charles C. Thomas, 1966.
3. Klein MJ. Chapter 1 in Practical Orthopedic Pathology (a volume in the Pattern Recognition Series edited by Kevin O. Leslie and Mark R. Wick), Siegal GP, DeYoung BR, eds. Philadelphia, PA: Churchill Livingstone, in press.
4. Jowsey J. The Bone Biopsy. New York, NY: Plenum Medical Book Co.; 1977.
5. Bullough P, Goodfellow J. The significance of the fine structure of articular cartilage. J Bone Joint Surg Br 1968; 50: 852–857.
6. Hyttinen MM, Arokoski JP, Parkkinen JJ, et al. Age matters: collagen birefringence of superficial articular cartilage is increased in young guinea-pigs but decreased in older animals after identical physiological type of joint loading. Osteoarthritis Cartilage 2001; 9: 694–701.
7. Minns RJ, Steven FS. The collagen fibril organization in human articular cartilage. J Anat 1977; 123: 437–457.
8. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11(4): 447–455.
9. Scott JE. The histochemistry of cartilage proteoglycans in light and electron microscopy. In: Ali SY, Elves MW, Leaback DH, eds. Normal and Osteoarthrotic Articular Cartilage. London: Institute of Orthopaedics (University of London); 1974: 19–32.
10. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001; 12: 69–78.
11. Klein MJ, Bonar SF, Freemont T, et al. Non-neoplastic diseases of bones and joints. In Atlas of Non-Tumor Pathology. Silver Spring, MD: ARP Press; 2011.
12. Sokoloff L. Note on the histology of cement lines. In: Kenedi RM, ed. Perspectives in Biomedical Engineering. London: MacMillan; 1973: 135.
13. McCarthy EF, Frassica FJ. Pathology of Bone and Joint Disorders with Clinical and Radiographic Correlation. Philadelphia, PA: W.B. Saunders Company; 1998.
14. Bullough PG. Non-neoplastic diseases of bones and joints. In: Silverberg SG, DeLellis RA, Frable WJ, LiVolsi VA, Wick MR, eds. Silverberg’s Principles and Practice of Surgical Pathology. Philadelphia, PA: Churchill-Livingstone/Elsevier; 2006.
15. Enlow DH. Principles of Bone Remodeling. An Account of Postnatal Growth and Remodeling Processes in Long Bones and the Mandible. Springfield, IL: Charles C. Thomas; 1963.
16. Jaffe HL. Metabolic, Degenerative, and Inflammatory Diseases of Bones and Joints. Philadelphia, PA: Lea & Febiger; 1972.
17. Xie J, Baumann MJ, McCabe LR. Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J Biomed Mater Res A 2004; 71: 108–117.
18. Klein-Nulend J, Nijweide PJ, Burger EH. Osteocyte and bone structure. Curr Osteoporosis Rep 2003; 1: 5–10.
19. Liu S, Quarles D. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18: 1637–1647.
20. Cherian PP, Cheng B, Gu S, et al. Effects of mechanical strain on the function of gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J Biol Chem 2003; 278: 43146–43156.
21. Fujukawa Y, Quinn JM, Sabokar A, et al. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996; 137: 4058–4060.
22. Li Z, Kong K, Qi W. Osteoclast and its roles in calcium metabolism and bone development and remodeling. Biochem Biophys Res Commun 2006; 343; 345–350.
23. Riggs BL, Melton LJ. Osteoporosis: Etiology, Diagnosis, and Management. Philadelphia, PA: Lippincott-Raven Publishers; 1995.
24. Lowe RN, Azimi PH, McQuitty J. Acid-fast Actinomyces in a child with pulmonary actinomycosis. J Clin Microbiol 1980; 12: 124.
25. Johnston CC Jr, Lavy N, Lord T, et al. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) 1968; 47: 149–167.
26. Ham AW, Harris WR. Repair and transplantation of bone. In: Bourne GH, ed. Biochemistry and Physiology of Bone. New York, NY: Academic Press; 1971.
27. Cruess R, Dumont J. Healing of bone, tendon and ligament. In: Rockwood CA Jr, Green DP, eds. Fractures. Philadelphia, PA: Lippincott; 1975: 97.
28. Yamamoto T, Bullough PG. Subchondral insufficiency fracture of the femoral head: a differential diagnosis in acute onset of coxarthrosis in the elderly. Arthritis Rheum 1999; 42: 2719–2723.
29. Postel M, Kerboull M. Total prosthetic replacement in rapidly destructive arthrosis of the hip joint. Clin Orthop 1970; 72: 138–144.
30. Yamamoto T, Schneider R, Bullough PG. Insufficiency subchondral fracture of the femoral head. Am J Surg Pathol 2000; 24: 464–468.
31. Yamamoto T, Bullough PG. The role of subchondral insufficiency fracture in rapid destruction of the hip joint: a preliminary report. Arthritis Rheum 2000; 43: 2423–2427.
32. Urbaniak JR, Jones JP. Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1997.
33. Catto M. A histological study of avascular necrosis of the femoral head after transcervical fracture. J Bone Joint Surg Br 1965; 47: 749–776.
34. Bullough PG, Kambolis CP, Marcove RC, et al. Bone infarctions not associated with caisson disease. J Bone Joint Surg Am 1965; 47: 477–491.
35. Mirra JM, Bullough PG, Marcove RC, et al. Malignant fibrous histiocytoma and osteosarcoma in association with bone infarcts; report of four cases, two in caisson workers. J Bone Joint Surg Am 1974; 56: 932–940.
36. Slavin RE, Wen J, Kumar D, Evans EB. Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis. Am J Surg Pathol 1993; 17: 788–802.
37. Topaz O, Indelman M, Chefetz I, et al. A deleterious mutation in SMAD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet 2006; 79: 759–764.
38. Paterson DC. Myositis ossificans circumscripta. Report of four cases without history of injury. J Bone Joint Surg Br 1970; 52: 296–301.
39. Smith R. Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease. Clin Orthop 1998; 346: 7–14.
40. Kaplan FS, Glaser DL, Shore EM, et al. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005; 3: 183–188.
41. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 1982; 64: 76–83.
42. Kaplan FS, Craver R, MacEwen GD, et al. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Joint Surg Am 1994; 76: 425–436.
43. Kaplan FS, LeMerrer M, Glaser DL, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008; 22: 191–205.
44. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004; 12: 116–1250.
45. Trelstad RL, Rubin D, Gross J. Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen. Lab Invest 1977; 36: 501–508.
46. Byers PH. Disorders of collagen biosynthesis and structure. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001: 5241–5286.
47. Paschalis EP, Tatakis DN, Robins S, et al. Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral. Bone 2011; 49(6): 1232–1241.
48. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001: 3421–3452.
49. Teitelbaum SL, Rosenberg EM, Bates M, Avioli LV. The effects of phosphate and vitamin D therapy on osteopenic, hypophosphatemic osteomalacia of childhood. Clin Orthop 1976; 116: 38–47.
50. Malluche HH, Faugere MC, Smith AJ Jr, Friedler RM. Aluminum intoxication of bone in renal failure – fact or fiction? Kidney Int Suppl 1986; 18: S70–73.
51. Epker BN. A quantitative histologic study of the effects of fluoride on resorption and formation in animal and human bone. Clin Orthop 1966; 49: 77–87.
52. Lowe H, McMahon DJ, Rubin MR, Bilizikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007; 92: 3001–3005.
53. Wilde CD, Jaworski ZF, Villanueva AR, Frost HM. Quantitative histological measurements of bone turnover in primary hyperparathyroidism. Calcif Tissue Res 1973; 12: 137–142.
54. Teitelbaum SL, Bullough PG. The pathophysiology of bone and joint disease. Am J Pathol 1979; 96: 282–354.
55. Hamerman D, Rosenberg LC, Schubert M. Diarthrodial joints revisited. J Bone Joint Surg Am 1970; 52: 725–774.
56. Hannan FM, Ahanasou NA, Teh J, et al. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25 dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 2008; 158: 265–271.
57. Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 1987; 106: 444–450.
58. Wilson AJ, Murphy WA, Hardy DC, Totty WG. Transient osteoporosis: transient bone marrow edema? Radiology 1988: 176: 757–760.
59. Bullough PG. Massive osteolysis. N Y State J Med 1971; 71: 2267–2278.
60. Atalabi OM, Fishman SJ, Kozakewich HP, et al. A lethal form of Gorham disease associated with extensive musculoskeletal pneumatosis: case report and review of the literature. Skeletal Radiol 2008; 37: 1041–1046.
61. Coe FL, Favus MJ. Disorders of Bone and Mineral Metabolism. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
62. Barry H. Paget’s Disease of Bone. Edinburgh: Livingstone; 1969.
63. Rebel A, Malkani K, Basle M, Bregeon C. Osteoclast ultrastructure in Paget’s disease. Calcif Tissue Res 1976; 2: 187–199.
64. Cundy T. Is the prevalence of Paget’s disease of bone decreasing? J Bone Miner Res 2006; 21(Suppl 2): P9–13.
65. Price CH, Goldie W. Paget’s sarcoma of bone. A study of eighty cases from the Bristol and the Leeds bone tumour registries. J Bone Joint Surg Br 1969; 51: 205–224.
66. Ralston SH. Juvenile Paget’s disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol 2008; 22(1): 101–111.
67. Whyte, MP. Paget’s disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Ann N Y Acad Sci 2006; 1068: 143–164.
68. Whalen JP, Horwith M, Krook L, et al. Calcitonin treatment in hereditary bone dysplasia with hyperphosphatasemia: a radiographic and histologic study of bone. Am J Roentgenol 1977; 129: 29–35.
69. Gaines JJ Jr. The pathology of alkaptonuric ochronosis. Hum Pathol 1989; 20: 40–46.
70. O’Brien WM, Banfield WG, Sokoloff L. Studies on the pathogenesis of ochronotic arthropathy. Arthritis Rheum 1961; 4: 137–152.
71. Kinnett JG, Bullough PG. Identification of calcium oxalate deposits in bone by electron diffraction. Arch Pathol Lab Med 1976; 100: 656–658.
72. McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease. Br J Rheumatol 1993; 32: 177–179.
73. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000 289: 265–270.
74. Zhang Y, Johnson K, Russell RG et al. Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5ʹ-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum 2005; 52: 1110–1117.
75. Zhang Y, Brown MA. Genetic studies of chondrocalcinosis. Curr Opin Rheumatol 2005; 17: 330–335.
76. Rosenthal AK. Update in calcium deposition diseases. Curr Opin Rheumatol 2007; 19: 158–162.
77. Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 2281–2313.
78. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001: 3635–3668.
79. Lazzarini L, Mader JT, et al. Osteomyelitis in long bones. J Bone Joint Surg Am 2004; 86A: 2305–2318.
80. Green NE, Edwards K. Bone and joint infections in children. Orthop Clin North Am 1987; 18: 555–576.
81. Fechner RE, Mills SE. Tumors of the Bones and Joints. Washington, DC: Armed Forces Institute of Pathology; 1993.
82. Dorfman HD, Czerniak B. Bone Tumors. St. Louis, MO: Mosby; 1998.
83. Bullough PG. Joints. In: Sternberg SS, ed. Histology for Pathologists. Philadelphia, PA: Lippincott-Raven; 1997: 107–126.
84. Hardingham TE. Articular cartilage. In: Isenberg DA, et al., eds. Oxford Textbook of Rheumatology. Oxford: Oxford University Press; 2004: 325–333.
85. Paget S, Bullough PG. Synovium and synovial fluid. In: Owen R, Goodfellow JW, Bullough PG, eds. Scientific Foundation of Orthopaedics and Traumatology. Philadelphia, PA: Saunders; 1980: 18–22.
86. Yester JW, Newrock RS. How the red-I compensator works. Resident and Staff Physician 1980; 9: 76–82.
87. Nichols EH, Richardson FL. Arthritis deformans. J Med Res 1909; 21: 149–221.
88. Meisel AD, Bullough PG, Twersky J. Atlas of Osteoarthritis. Philadelphia, PA: Lea & Febiger; 1984.
89. Perry GH, Smith MJ, Whiteside CG. Spontaneous recovery of the joint space in degenerative hip disease. Ann Rheum Dis 1972; 31: 440–448.
90. Firestein GS. Rheumatoid synovitis and pannus. In: Hochberg MC, Silman AJ, Smolen JS, et al., eds. Rheumatology. Edinburgh: Mosby; 2003: 855–884.
91. Klippel JH, Weyand CM, Crofford LJ, Stone JH. Primer on the Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 2001.
92. Nepom B, King RA. Rheumatoid arthritis. In: King RA, Rotter JI, Motulsky AG, eds. The Genetic Basis of Common Diseases. Oxford: Oxford University Press; 2002: 587–603.
93. Sokoloff S. Pathophysiology of peripheral blood vessels in collagen diseases. In: Orbison JL, Smith DE, eds. The Peripheral Blood Vessels. Baltimore, MD: Williams & Wilkins; 1963.
94. Haynes MK, Hume EL, Smith JB. Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clin Immunol 2002; 105: 315–325.
95. Hannouche D, Hammadouche M, Nizard R, et al. Ceramics in total hip replacement. Clin Orthop Rel Res 2005; 430: 62–71.
96. Urban RM, Jacobs JJ, Tomlinson MJ, et al. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacements. J Bone Joint Surg Am 2000; 82: 457–476.
97. DiCarlo EF, Bullough PG. The biologic responses to orthopedic implants and their wear debris. Clin Mater 1992; 9: 235–260.
98. Willert HG, Semlitsch M. Tissue reactions to plastic and metallic wear products of joint endoprostheses. Clin Orthop 1996; 333: 4–14.
99. Davies AP, Willert HG, Campbell PA, et al. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am 2005; 87: 18–27.
100. Freemont AJ, Jones CJ, Bromley M, Andrews P. Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum 1983; 26: 1427–1433.
101. Fujishiro T, Moojen DJ, Kobayashi N, et al. Perivascular and diffuse lymphocytic inflammation are not specific for failed metal-on-metal hip implants. Clin Orthop Rel Res 2011; 469(4): 1127–1133.
102. Watters TS, Cardona DM, Menon KS, et al. Aseptic lymphocyte-dominated vasculitis-associated lesion: a clinicopathologic review of an underrecognized cause of prosthetic failure. Am J Clin Pathol 2010; 134(6): 886–893.
103. Hanssen AD, Rand JA. Instructional course lectures. American Academy of Orthopedic Surgeons. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg Am 1998; 80: 910–922.
104. Byers PD, Cotton RE, Deacon OW, et al. The diagnosis and treatment of pigmented villonodular synovitis. J Bone Joint Surg Br 1968; 50: 290–305.
105. Schwartz HS, Unni KK, Pritchard DJ. Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop 1989; 247: 243–255.
106. Villacin AB, Brigham LN, Bullough PG. Primary and secondary synovial chondrometaplasia: histopathologic and clinicoradiologic differences. Hum Pathol 1979; 10: 439–451.
107. Bertoni F, Unni KK, Beabout JW, Sim FH. Chondrosarcomas of the synovium. Cancer 1991; 67: 155–162.
108. Smillie IS. Injuries of the Knee Joint. London: Churchill Livingstone; 1978.
109. Kambolis C, Bullough PG, Jaffe HI. Ganglionic cystic defects of bone. J Bone Joint Surg Am 1973; 55: 496–505.
110. Phalen GS. The birth of a syndrome, or carpal tunnel revisited. J Hand Surg [Am] 1981; 6: 109–110.
111. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10. N Engl J Med 1972; 286: 534–539.
112. Asbury AK, Johnson PC. Pathology of Peripheral Nerve. Philadelphia, PA: Saunders: 1978.
113. Schmorl G. The displacement of intervertebral disc tissue in the human spine. In: Junghanns H, Besemann EF, eds. Health and Disease. Orlando, FL: Grune & Stratton; 1971: 158–184.
114. Bullough PG, Boachie-Adjei O. Atlas of Spinal Diseases. New York, NY: Gower Medical Publishing; 1988.